Target intelligence / Profile preview

Lipid peroxidation (mediated by reactive oxygen species)

Molecular classification
Other (not a discrete gene/protein, but a biochemical process)
01

Overview

Lipid peroxidation refers to the oxidative degradation of membrane lipids, most often polyunsaturated fatty acids, by reactive oxygen species (ROS) such as hydroxyl radicals, superoxide, and hydrogen peroxide. This process disrupts membrane structure, permeability, and fluidity, ultimately leading to cellular dysfunction or death. Oxidized lipid byproducts (e.g., malondialdehyde, 4-hydroxynonenal) can act as signaling molecules that drive apoptosis, ferroptosis, and inflammatory cascades. While not a conventional drug target like a receptor or enzyme, the process is central to the pathogenesis of diseases involving oxidative stress—including cancer, neurodegeneration, and cardiovascular conditions. Intervention strategies often focus on scavenging ROS, preventing iron-catalyzed radical generation, or enhancing endogenous antioxidant enzyme pathways. The measurement of lipid peroxidation products serves as important biomarkers for oxidative injury in research and clinical contexts.

Other names
lipid oxidationoxidative damage to membrane lipidsROS-mediated lipid peroxidation
02

Mechanism of action

Scavenging or neutralization of ROS to prevent lipid peroxidation (antioxidants); Inhibiting iron-dependent ROS generation to block ferroptosis (iron chelators); Enhancing reduction of lipid hydroperoxides via GPX4 agonists or mimetics

03

Biological functions

Cell death (apoptosis, ferroptosis, necrosis)Signal transductionCell membrane structural remodelingInflammatory response
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationOther (multiple organ dysfunction, chronic illnesses involving oxidative stress)
05

Safety considerations

Non-specific targeting (antioxidants and iron chelators may disrupt physiological ROS signaling)Potential for impaired immune responseOver-suppression of ROS may compromise normal cellular signaling and homeostasis
06

Interacting drugs

Antioxidants (e.g., vitamin E, N-acetylcysteine, ferrostatin-1)

2 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)4-hydroxynonenal (4-HNE)Lipid hydroperoxides (LOOH)TBARS (thiobarbituric acid reactive substances) assay

Beyond the preview

Go deeper on Lipid peroxidation (mediated by reactive oxygen species).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipid peroxidation (mediated by reactive oxygen species).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call